Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SCN9A | Q15858 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.31 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.31 |
| ▸ | CHRM5 | P08912 | 1/20 | 0.31 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.31 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5672306 | 0.74 | CYP3A4 (0.38) | SCN9AALDH1A1SIGMAR1EPHX2 | |
| SCHEMBL28318181 | 0.72 | KDM1A (0.47) | — | |
| SCHEMBL28174692 | 0.72 | SIGMAR1 (0.41) | SCN9ASIGMAR1EPHX2 | |
| SCHEMBL10012943 | 0.72 | EPHX2 (0.35) | SCN9ASIGMAR1EPHX2 | |
| SCHEMBL5346555 | 0.72 | EPHX2 (0.36) | SCN9AHSD17B10SIGMAR1EPHX2 | |
| SCHEMBL9721529 | 0.72 | HTR2C (0.42) | ALDH1A1SIGMAR1 | |
| SCHEMBL345589 | 0.72 | HTR2A (0.42) | SCN9AALDH1A1HSD17B10EPHX2 | |
| SCHEMBL2710116 | 0.70 | ALDH1A1 (0.41) | SCN9AALDH1A1HTTHSD17B10EPHX2 | |
| SCHEMBL3629131 | 0.69 | KDM1A (0.52) | ALDH1A1HSD17B10 | |
| SCHEMBL27694917 | 0.69 | CHRNB2 (0.40) | ALDH1A1HSD17B10SIGMAR1EPHX2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-2006526672-A | — | — | 2006-11-24 | — | — | JP | claimed |
| US-20060180900-A1 | Organo-silsesquioxane polymers for forming low-k dielectrics | SILECS OY (FI) | 2006-08-17 | — | — | US | claimed |
| WO-2004090019-A1 | ORGANO-SILSESQUIOXANE POLYMERS FOR FORMING LOW-K DIELECTRICS | SILECS OY (FI) | 2004-10-21 | — | — | WO | claimed |
| US-7622399-B2 | Method of forming low-k dielectrics using a rapid curing process | SILECS OY (FI) | 2009-11-24 | — | — | US | disclosed |
| US-20090278254-A1 | Dielectric materials and methods for integrated circuit applications | SILECS OY (FI) | 2009-11-12 | — | — | US | disclosed |
| US-7514709-B2 | Organo-silsesquioxane polymers for forming low-k dielectrics | SILECS OY (FI) | 2009-04-07 | — | — | US | disclosed |
| US-20070063188-A1 | Low-k dielectric material | SILECS OY (FI) | 2007-03-22 | — | — | US | disclosed |
| US-20060180900-A1 | Organo-silsesquioxane polymers for forming low-k dielectrics | SILECS OY (FI) | 2006-08-17 | — | — | US | disclosed |
| US-20050064726-A1 | Method of forming low-k dielectrics | SILECS OY (FI) | 2005-03-24 | — | — | US | disclosed |
| US-20050032357-A1 | Dielectric materials and methods for integrated circuit applications | SILECS OY (FI) | 2005-02-10 | — | — | US | disclosed |
| WO-2004090019-A1 | ORGANO-SILSESQUIOXANE POLYMERS FOR FORMING LOW-K DIELECTRICS | SILECS OY (FI) | 2004-10-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070063188-A1 | Low-k dielectric material | KCNH3, KCNH2, KCNN3 | SCN9A 127/4885ALDH1A1 2343/4885HTT 4794/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.